We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1t4k

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1t4k.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1t4k.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1t4k| PDB=1t4k | SCENE= }}
{{STRUCTURE_1t4k| PDB=1t4k | SCENE= }}
-
'''Crystal Structure of Unliganded Aldolase Antibody 93F3 Fab'''
+
===Crystal Structure of Unliganded Aldolase Antibody 93F3 Fab===
-
==Overview==
+
<!--
-
Catalytic aldolase antibodies, generated by reactive immunization, catalyze the aldol reaction with the efficiency of natural enzymes, but accept a much broader range of substrates. Two separate groups of aldolase antibodies that catalyze the same aldol reactions with antipodal selectivity were analyzed by comparing their amino acid sequences with their crystal structures, site-directed mutagenesis data, and computational docking of the transition states of the aldol reaction. The crystal structure of aldolase antibody 93F3 Fab' at 2.5A resolution revealed a combining site with two lysine residues, including LysL89 that reacts to form the covalent enamine intermediate. In contrast, antibody 33F12 has one active site lysine, LysH93. The reactive lysine residues in each group of antibodies are differentially located on the heavy and light chain variable regions in pseudo-symmetric opposite orientations, but both within highly hydrophobic environments. Thus, the defining feature for the observed enantioselectivities of these aldolase antibody catalysts is the respective location and relative disposition of the reactive lysine residues within the active sites of these catalysts.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15491612}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15491612 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15491612}}
==About this Structure==
==About this Structure==
Line 26: Line 30:
[[Category: Enantioselectivity]]
[[Category: Enantioselectivity]]
[[Category: Reactive lysine]]
[[Category: Reactive lysine]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:31:11 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 10:38:58 2008''

Revision as of 07:39, 29 July 2008

Image:1t4k.png

Template:STRUCTURE 1t4k

Crystal Structure of Unliganded Aldolase Antibody 93F3 Fab

Template:ABSTRACT PUBMED 15491612

About this Structure

Full crystallographic information is available from OCA.

Reference

The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis., Zhu X, Tanaka F, Hu Y, Heine A, Fuller R, Zhong G, Olson AJ, Lerner RA, Barbas CF 3rd, Wilson IA, J Mol Biol. 2004 Nov 5;343(5):1269-80. PMID:15491612

Page seeded by OCA on Tue Jul 29 10:38:58 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1t4k"
Personal tools